This will 10 bag easy for the patient holders. They dont seem to like issuing additional shares more than they need to and have a great pipeline for organic growth. The also dont like debt! CEO and CFO are major holders so dont want dilution anymore than we do. Id like to see them team up with APX in some way to further their ai market aspirations. What a great Aussie combo that would be! A big question in my mind is what further products will the be able to produce and to what market can they deliver them to? Livetiles products are cheap which is good but also requires a lot of customer's to produce big revenues. Say 100 millions revenues. Joint ventures with larger company's with big customer bases are key imo
LVT Price at posting:
54.0¢ Sentiment: Buy Disclosure: Held
